To further explore the role of anti-PD-L1 antibody in BC radiotherapy, miR-21+/+ mouse tumor models in situ were established and the BC mice were treated with radiotherapy or anti-PD-L1 antibody. This evidence concerns the gene CD274 and neoplasm.